Cargando…
Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review
BACKGROUND: Due to economical and ethical reasons, the two-stage designs have been widely used for Phase 2 single-arm trials in oncology because the designs allow us to stop the trial early if the proposed treatment is likely to be ineffective. Nonetheless, none has examined the usage for published...
Autores principales: | Yoo, Wonsuk, Kim, Seongho, Garcia, Michael, Mehta, Shwetal, Sanai, Nader |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773486/ https://www.ncbi.nlm.nih.gov/pubmed/36550391 http://dx.doi.org/10.1186/s12874-022-01810-7 |
Ejemplares similares
-
A Phase 0 Trial of Ceritinib in Patients with Brain Metastases and Recurrent Glioblastoma
por: Mehta, Shwetal, et al.
Publicado: (2022) -
Modified Simon’s minimax and optimal two-stage designs for single-arm phase II cancer clinical trials
por: Kim, Jongphil, et al.
Publicado: (2019) -
Phase 0 Clinical Trial Strategies for the Neurosurgical Oncologist
por: Sanai, Nader
Publicado: (2019) -
Optimal two-stage design of single arm Phase II clinical trials based on median event time test
por: Park, Yeonhee
Publicado: (2021) -
Phase II trial designs for complex interventions: a single-arm single-stage design for clustered continuous outcomes
por: Wilson, Duncan T, et al.
Publicado: (2015)